Sharon L. Walsh, PhD

Dr. Walsh’s research has evaluated clinically relevant pharmacologic aspects of methadone and buprenorphine as well as the abuse liability of prescription opioids. She has served on FDA advisory panels evaluating new tamper resistant drug formulations and has taught doctors about the clinical pharmacology of buprenorphine and other opioids. She is also the past President of the College on Problems of Drug Dependence.